Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILDAGLIPTIN for Ketosis-prone diabetes mellitus: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where VILDAGLIPTIN was used for Ketosis-prone diabetes mellitus.

Most Reported Side Effects for VILDAGLIPTIN

Side Effect Reports % Deaths Hosp.
Pemphigoid 495 24.0% 3 228
Hypoglycaemia 121 5.9% 5 89
Acute kidney injury 120 5.8% 4 108
Blood glucose increased 98 4.8% 2 30
Lactic acidosis 98 4.8% 13 86
Malaise 87 4.2% 1 29
Dyspnoea 84 4.1% 4 52
Drug ineffective 82 4.0% 0 30
Vomiting 72 3.5% 3 60
Diabetes mellitus 69 3.3% 6 16
Hyperglycaemia 69 3.3% 7 21
Weight decreased 66 3.2% 3 28
Fall 65 3.2% 5 43
Diarrhoea 63 3.1% 4 37
Diabetes mellitus inadequate control 62 3.0% 0 21

Other Indications for VILDAGLIPTIN

Type 2 diabetes mellitus (814) Diabetes mellitus (529) Product used for unknown indication (508) Insulin-requiring type 2 diabetes mellitus (30) Blood glucose abnormal (9) Suicide attempt (8) Blood glucose increased (6) Diabetes mellitus management (6) Parkinson's disease (6) Glucose tolerance impaired (5)

Other Drugs Used for Ketosis-prone diabetes mellitus

INSULIN GLARGINE (34) INSULIN ASPART (17) LIRAGLUTIDE (11) GLIMEPIRIDE (7) INSULIN LISPRO (6) METFORMIN (5)

Related Pages

VILDAGLIPTIN Full Profile All Ketosis-prone diabetes mellitus Drugs VILDAGLIPTIN Demographics VILDAGLIPTIN Timeline